Advertisement
Building its own subsidiary reflects ThalesNano's commitment to bridgingcloser ties with its customers and expanding operations globally; it isintended to enhance activities in particular towards the chemical andpharmaceutical sectors, and to reinforce visibility. The UK representativeswill bring both added value in operational terms and flexibility forcustomers.
Advertisement
Alex Drijver, CFO commented: "Chemists will have a local point of contactfor advice on the most up-to-date chemistry technologies and solutions.ThalesNano Inc. was already operating successfully through a distributorcompany in the UK and can now strengthen and consolidate its position withhelp of its local team of professionals. The UK is a strategic market for thecompany's growth, as the country's R&D spending is the largest within Europeand has the most developed and innovative pharmaceutical and chemicalindustry. In this way, ThalesNano Inc. can effectively support UK customersat all times with the necessary technology knowledge."
The new UK ThalesNano team replaces former distributor Asynt Inc., withwhom the company's contract expired in September. The Danish distributorcompany, Biolab A/S is taking over customers from Asynt Inc. in theScandinavian region. While in Italy, Stepbio S.R.L. is the new distributor ofThalesNano products.
As a result of ThalesNano's global expansion, and as a response to thedemand for its products and technologies from India, the company has startedits operation through cooperation with Inkarp Instruments Pvt. Ltd.
Dr. Ferenc Darvas, president and chairman commented: "The development andgrowth of both ThalesNano's sales team and the distributor network comes twoyears after the initial launch of the award winning H-Cube(R), which israpidly becoming the standard for performing hydrogenation reactions inresearch laboratories."
For more information please visit http://www.thalesnano.com
About ThalesNano Inc.:
ThalesNano Inc. is a technology-intensive company that provides solutionsfor leading pharmaceutical and biotechnology companies from all over theworld. It is specialized in developing and providing microscale flowinstruments for chemistry, by exploiting the benefits of combiningmicrofluidics, mezofluidics or nanotechnology with flow chemistry.
The award winning development, H-Cube(R), has been recognized as one ofthe 100 most technologically significant and innovative new products of 2005by R&D Magazine is the first in a new wave of continuous-flow hydrogenationreactors.
SOURCE Thalesnano Nanotechnology Inc
